Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1994
[Early phase II study of MST-16 (sobuzoxane) for breast cancer]T Tominaga, K Shimozuma, K Hasegawa, et al.DNA and Cell Biology|September 24, 1999
An intronic NF-kappaB element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-alpha and interleukin-1betaY Xu, K K Kiningham, M N Devalaraja, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1993
[Phase I Study of RA-700. RA-700 Clinical Study Group]H Majima, S Tsukagoshi, H Furue, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1992
[A phase I study of DWA2114R]Y Ariyoshi, A Wakui, K Hasegawa, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1991
[Evaluation of cardiotoxicity in new anthracycline analog ME 2303. ME 2303 Study Group]K Okuma, Y Ariyoshi, A Wakui, et al.Journal of Pharmacobio-Dynamics|October 1, 1987
Pharmacokinetic studies on 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea (TA-077). III. Pharmacokinetics of a new nitrosourea antitumor agent TA-077 in humans (a phase I study)K Hayashida, Y Miura, Y Arai, et al.Oncogene|February 2, 1999
Mutations in the promoter reveal a cause for the reduced expression of the human manganese superoxide dismutase gene in cancer cellsY Xu, A Krishnan, X S Wan, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1982
[Phase I study of a new anticancer agent CAM--results of cooperative study]T Saito, I Nakao, A Wakui, et al.Cancer Letters|July 9, 1999
Evidence for mRNA expression of vascular endothelial growth factor by X-ray irradiation in a lung squamous carcinoma cell lineS Ando, K Nojima, H Majima, et al.Cancer Research|August 17, 2001
Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis modelY Zhao, Y Xue, T D Oberley, et al.Pageof 7